Printer Friendly


 /NOTE TO EDITORS: The products described in the release below are available in select pharmacies in Connecticut; New York, N.Y.; Long Island, N.Y.; Westchester County, N.Y.; New Jersey; Philadelphia, Pa.; Tampa, Fla.; Miami, Fla.; Atlanta, Ga.; Chicago, Ill.; San Francisco, Calif.; and Los Angeles, Calif./
 COLLEGEVILLE, Pa., June 17 /PRNewswire/ -- One of Europe's leading skin-care companies, RoC S.A., and a U.S. dermatology company, Dermik Laboratories, Inc., today announced market entry of a new line of skin- care products. Educational and sales efforts will be focused toward dermatologists and pharmacists. Taking a unique marketing approach, these products will be available in select pharmacies. Dermik Laboratories, Inc., is a subsidiary of Rhone-Poulenc Rorer, Inc. (NYSE: RPR). RoC S.A. is a member of the Moet-Hennessy-Louis-Vuitton group.
 "More and more dermatologists are called on by patients to consult on daily skin-care regimens, not only to treat acute disease," said Nia Terezakis, M.D., clinical professor of dermatology, Tulane Medical School, New Orleans. "Skin-care approaches such as RoC's allow dermatologists to participate more fully in meeting their patients' total health needs."
 In Europe, doctors have already taken the total patient care approach. Now, U.S. consumers are seeking out skin-care information from the source they trust most, their health-care provider. Market research studies show that 82 percent of patients already consult their physicians about over-the-counter products.
 "With the emphasis on health in the 1990s -- physical fitness, nutrition, reading food labels -- American consumers are becoming just as concerned about what they apply to their skin as what they eat," said Henrietta Cole, owner of Jeffersonville, Pennsylvania Medicine Shoppe, who has been providing RoC products to her retail pharmacy customers for two months as part of a test-market study. "As health-care policy continues to evolve, the pharmacist's role as a counselor will become vital to guide these consumers about appropriate OTC and prescription choices."
 Products in the RoC line are without perfume, contain no unnecessary ingredients and have been clinically proven to be hypo-allergenic and non-comedogenic. Moreover, RoC does not perform any animal testing. All RoC products, ingredients and manufacturing processes undergo continuous reevaluation and revision to ensure that safe and effective materials are used.
 The RoC Product Line
 For the past 36 years, RoC has marketed a leading line of hypo- allergenic skin-care products throughout the world. Founded in 1957 by French pharmacist Jean-Charles Lissarrague, the RoC line includes products that are market leaders in 50 countries.
 "With annual sales of $130 million, RoC is a dominant player throughout the world," said Remy Gomez, president, RoC S.A. "Successful entry into the U.S. marketplace will strengthen our position as global leaders in quality skin-care products."
 The six new skin-care products are:
 -- Hydra+ Integral Optimum Moisturizing Facial Cream. Maintains optimum moisturization for all skin types; reduces transepidermal water loss and reinforces the hydro-lipidic film. Suggested retail price: $14.00/1.4 oz.
 -- RoC Enriched Treatment Cream. Improves hydration in very dry skin conditions; increases comfort and softens the skin. Suggested retail price: $13.00/1.7 oz.
 -- RoC Gel Cleansing Wash. Gentle, effective cleansing for oily, problem skin; thoroughly cleanses without irritating or causing rebound sebum secretion. Suggested retail price: $9.50/4.2 fl. oz.
 -- RoC Shine Control Cream. Moisturization and maintenance for oily skin; absorbs excess sebum secretion, providing matte appearance. Suggested retail price: $9.50/1.0 oz.
 -- RoC Intensive Hand Care Cream. Water-resistant care for dry, rough or damaged hands; restores hydration and enhances softness; contains protective, moisturizing, film-forming ingredients. Suggested retail price: $10.00/2.6 oz.
 -- Hydra+ Corps Optimum Moisturizing Body Lotion. Balanced, prolonged hydration for the body; reduces transepidermal water loss and reinforces the cohesion of corneocytes; restores skin's hydro-lipidic film. Suggested retail price: $12.50/6.8 fl. oz.
 "I've been recommending RoC products right along with prescription products to my patients," said Rose Saperstein, M.D., dermatologist, who participated in the test marketing in Beverly Hills, Calif. "The response has been very positive, particularly among patients who have sensitive skin."
 The RoC Concept
 Robert Rietschel, M.D., head of dermatology, Ochsner Clinic, chairman of the American Academy of Dermatology Cosmetic Toiletries and Fragrance Association Liaison Committee, said, "The medical community is still seeking agreement on the definition of hypo-allergenicity. While we work to determine scientific standards, I feel confident that recommending RoC products to my patients will minimize their risk of allergic skin reaction based on the ingredients and laboratory and clinical testing."
 According to one study, 48 percent of reported cases of contact dermatitis are cosmetic-related (Note A). Fragrance is the leading cause of contact and cosmetic dermatitis, and preservatives are reported as the second leading allergen (Note B). All RoC products are developed based on a skin-care concept emphasizing quality control for patient care.
 -- Hypo-allergenic. The risk of skin reaction is minimized in every RoC product.
 -- Without perfume. Perfume does nothing to improve the skin's appearance, and may cause allergic reaction. All RoC products are fragrance-free with no masking agents.
 -- Non-comedogenic. RoC finished products and raw materials are all selected and tested to ensure they don't encourage blackhead formation.
 -- Hospital- and laboratory-tested. New raw materials and finished RoC products are clinically tested on 100 to 200 patients, and no animal testing is done.
 -- Pure formulas. No unnecessary additives are ever used in RoC products, and fewer ingredients are used than in many comparable products.
 -- Strict ingredient selection. Each RoC ingredient is selected for optimum effectiveness, proven safety and cosmetic acceptability.
 -- Manufacturing and quality control. Production of RoC products is in accordance with pharmaceutical industry standards.
 -- Specially designed packaging. RoC packaging preserves products in optimum conditions, and minimizes contamination to allow for fewer preservatives.
 -- Supplementary information. All RoC products include a list of ingredients and are expiration-dated.
 RoC products are available in select pharmacies in New York City including Westchester County and Long Island, and in Philadelphia, Atlanta, Tampa, Miami, Chicago, Los Angeles and San Francisco. The products are also available statewide in Connecticut and New Jersey. Within the next two months, RoC products will be introduced in Boston, Washington, D.C., Pittsburgh, Cincinnati, Minneapolis, Dallas, Phoenix and San Diego. To locate participating pharmacies, patients, consumers and dermatologists can contact:

Interested consumers are encouraged to consult their dermatologists to identify which products are right for them.
 RoC S.A. already markets its products in more than 50 countries, selling approximately 30 million units. Approximately $6 million in annual sales is dedicated to research.
 Dermik Laboratories, Inc., a company dedicated to dermatology, develops and markets both prescription and over-the-counter pharmaceuticals for treating dermatologic disorders. Annual sales in 1992 were approximately $62 million. The aim of its joint venture with RoC S.A. is to bring to market products that complement the therapeutic needs of dermatologists.
 (A) -- Adams RM, Maibach HI. A five-year study of cosmetic reactions. The Journal of the American Academy of Dermatology. 1985;13:1062-1069.
 (B) -- Durupt G, Franck MF. Preservatives in dermatology. Bulletin d'esthetique dermatologique et de cosmetologie. 1990;58.
 -0- 6/17/93
 /NOTE TO EDITORS: Black and white, color photos available/
 /CONTACT: Robert Partridge, 215-454-3890, for Dermik Laboratories/

CO: Dermik Laboratories, Inc.; RoC S.A. ST: Pennsylvania IN: HOU SU: PDT

LD-GK -- NY003 -- 2916 06/17/93 09:02 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 17, 1993

Related Articles
Advanced Polymer Systems Announces Expanded Agreement With Dermik Laboratories And Initiation of Phase III Study of Microsponge(R)-Entrapped...
$1 Million Research Grant Received by the Dermatology Foundation From Dermik Laboratories, Inc.
BenzaClin(TM) Topical Gel Can Now Be Stored At Room Temperature.
Aventis division Dermik announces acquisition of New-Fill, Poly-lactic implant; advance is long-lasting synthetic for facial contouring.
VFW's Operation Uplink Receives 40,000 Phone Cards Donated by Penlac(TM) Nail Lacquer (ciclopirox) Topical Solution, 8%; Dermik Laboratories'...
Aventis Division Dermik Announces Acquisition of New-Fill(R), Poly-Lactic Implant; Advance Is Long-Lasting Synthetic for Facial Contouring; Product...
Bioiberica S.A.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters